AKT1 and esophageal squamous cell carcinoma: Regarding the potential molecular mechanism underlying this phenomenon, a previous study reported that ITGA2 silencing inhibits FAK/AKT signaling, thereby decreasing cell proliferation in esophageal squamous cell carcinoma [17].